The Journal of Organic Chemistry
ARTICLE
0.48 mmol) and 6-chloro-1-hexyne (90 μL, 0.74 mmol), the reaction
was stirred for 25 h at rt. Column chromatography on silica gel (eluting
with 1% EtOAc/hexanes) afforded the product as a pale yellow oil (70
mg, 66%). 1H NMR (400 MHz, CDCl3) δ 7.35 (d, J = 8.8 Hz, 2H), 6.83
(d, J = 8.8 Hz, 2H), 3.82 (s, 3H), 3.62 (t, J = 6.6 Hz, 2H), 2.45 (t, J = 7.0
Hz, 2H), 2.02-1.94 (m, 2H), 1.81-1.71 (m, 2H).10
3 mmol), PdCl2(Amphos)2 (3.5 mg, 0.005 mmol), 2 wt % of TPGS-750-
M (3 mL), TMEDA (116 mg, 1 mmol), ethyl 4-bromobutanoate (390 mg,
2 mmol), and ethyl bromobenzoate (229 mg, 1 mmol), the reaction was
stirred for 48 h at rt. Column chromatography on silica gel (eluting with
1
10% Et2O/petroleum ether) afforded the product (187 mg, 71%). H
NMR (500 MHz, CDCl3) δ 7.95 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.0 Hz,
2H), 4.35 (q, J = 7.5 Hz, 2H), 4.11 (q, J = 7.5 Hz, 2H), 2.69 (t, J = 7.5 Hz,
2H), 2.30 (t, J = 7.5 Hz, 2H), 1.95 (quint, J = 7.5 Hz, 2H), 1.37 (t,
J = 7.5 Hz, 3H), 1.24 (t, J = 7.5 Hz, 3H).42
2-(Cyclohexenylethynyl)naphthalene (Table 5, entry 6).
Following the general procedure using 2-bromonaphthalene (103 mg,
0.50 mmol) and 1-ethynylcyclohex-1-ene (100 μL, 0.85 mmol), the
reaction was stirred for 21 h at rt. Column chromatography on silica gel
(eluting with 1% EtOAc/hexanes) afforded the product as an off-white
Ethyl 4-Decylbenzoate (Table 6, entry 3). Following the
general procedure, using zinc powder (260 mg, 4 mmol), PdCl2-
(Amphos)2 (7 mg, 0.01 mmol), 2 wt % of TPGS-750-M (6 mL),
TMEDA (580 mg, 5 mmol), iododecane (804 mg, 3 mmol), and ethyl
bromobenzoate (229 mg, 1 mmol), the reaction was stirred for 36 h at rt.
Column chromatography on silica gel (eluting with 1% Et2O/petroleum
ether) afforded the product (258 mg, 89%). 1H NMR (500 MHz,
CDCl3) δ 7.95 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 4.35 (q, J =
7.5 Hz, 2H), 2.65 (t, J = 7.5 Hz, 2H), 1.63-1.60 (m, 2H), 1.38 (t, J = 7.5
Hz, 3H), 1.27-1.25 (m, 14H), 0.88 (t, J = 7.5 Hz, 3H); 13C NMR (125
MHz) δ 166.9, 148.6, 129.7, 128.5, 128.1, 60.9, 36.2, 32.1, 31.8, 29.8,
29.7, 29.6, 29.5, 29.4, 22.9, 14.5, 14.3; HRMS (C19H30O2) calcd
290.2246, found 290.2252.
(E)-((Dodec-4-en-1-yloxy)methyl)benzene (Table 6, entry
4). Following the general procedure, using zinc powder (260 mg, 4
mmol), PdCl2(Amphos)2 (7 mg, 0.01 mmol), 2 wt % of TPGS-750-M
(6 mL), TMEDA (580 mg, 5 mmol), 1-iodoheptane (678 mg, 3 mmol),
and (E)-(((5-iodopent-4-en-1-yl)oxy)methyl)benzene (302 mg, 1 mmol,
Z/E = 1/99), the reaction was stirred for 16 h at rt. Column
chromatography on silica gel (eluting with 5% EtOAc/petroleum ether)
afforded the product (231 mg, 84%, Z/E = 1/99). 1H NMR (400 MHz)
δ 7.35-7.34 (m, 4H), 7.30-7.27 (m, 1H), 5.45-5.36 (m, 2H), 4.50 (s,
2H), 3.48 (t, J = 6.6 Hz, 2H), 2.08 (q, J = 6.7 Hz, 2H), 1.97 (q, J = 6.7 Hz,
2H), 1.68 (quint, J = 7.0 Hz, 2H), 1.35-1.27 (m, 10H), 0.89 (t, J = 6.9
Hz, 3H); 13C NMR (100 MHz) δ 138.9, 131.3, 129.6, 128.6, 127.9,
127.7, 73.1, 70.1, 32.8, 32.1, 29.9, 29.8, 29.4, 29.4, 29.4, 22.9, 14.4;
HRMS (C19H30O) calcd 274.2297, found 274.2293.
1-((Z)-Non-1-enyl)benzene (Table 6, entry 5). Following the
general procedure, using zinc powder (260 mg, 4 mmol), PdCl2-
(Amphos)2 (7 mg, 0.01 mmol), 2 wt % of TPGS-750-M (6 mL),
TMEDA (580 mg, 5 mmol), 1-iodoheptane (678 mg, 3 mmol), and
1-((Z)-2-bromovinyl)benzene (183 mg, 1 mmol, Z/E = 99/1), the
reaction was stirred for 16 h at rt. Column chromatography on silica gel
(eluting with petroleum ether) afforded the product (182 mg, 90%,
Z/E = 88/12). 1H NMR (400 MHz) δ 7.34 (t, J = 7.7 Hz, 2H), 7.27 (d,
J = 6.9 Hz, 2H), 7.21 (t, J = 7.3 Hz, 1H), 6.40 (brd, J = 11.7 Hz, 1H), 5.67
(dt, J = 11.7, 7.3 Hz, 1H), 2.34 (dq, J = 7.5, 1.5 Hz, 2H), 1.47-1.42 (m,
2H), 1.31-1.26 (m, 8H), 0.88 (t, J = 7.1 Hz, 3H).43
(Z)-Ethyl Dodec-5-enoate (Table 6, entry 6). Following the
general procedure, using zinc powder (260 mg, 4 mmol), PdCl2-
(Amphos)2 (7 mg, 0.01 mmol), 2 wt % of TPGS-750-M (6 mL),
TMEDA (580 mg, 5 mmol), (Z)-1-bromooct-1-ene (181 mg, 1 mmol,
Z/E = 99/1), and ethyl 4-bromobutanoate (390 mg, 2 mmol), the
reaction was stirred for 12 h at rt. Column chromatography on silica gel
(eluting with 5% EtOAc/petroleum ether) afforded the product (196
mg, 87%, Z/E = 99/1). 1H NMR (400 MHz) δ 5.43-5.30 (m, 2H), 4.12
(q, J = 7.1 Hz, 2H), 2.28 (q, J = 7.6 Hz, 2H), 2.06 (q, J = 7.4 Hz, 2H), 2.00
(q, J = 7.7 Hz, 2H), 1.70-1.65 (m, 2H), 1.34-1.23 (m, 11H), 0.88 (t, J =
7.2 Hz, 3H); 13C NMR (100 MHz) δ 174.0, 131.3, 128.6, 60.4, 34.0,
32.0, 29.9, 29.2, 27.4, 26.7, 25.1, 22.9, 14.5, 14.3; HRMS (C14H26O2)
calcd 226.1933, found 226.1934.
1
solid (115 mg, 99%). H NMR (400 MHz, CDCl3) δ 7.95 (s, 1H),
7.82-7.76 (m, 3H), 7.50-7.45 (m, 3H), 6.29-6.27 (m, 1H), 2.30-
2.26 (m, 2H), 2.21-2.16 (m, 2H), 1.75-1.62 (m, 4H).10
General Procedure for Buchwald-Hartwig Amination
(Table 5). The catalyst [(π-allyl)PdCl]2 (2.1 mg, 0.006 mmol), ligand
cBRIDP (Takasago; 7.6 mg, 0.022 mmol), KO-t-Bu (184 mg, 1.56
mmol), and amine (1.20 mmol) were added under argon into a 5.0 mL
microwave vial equipped with a large stir bar and Teflon lined septum.
An aliquot of TPGS-750-M/H2O (1.0 mL; 2.0% TPGS-750-M by
weight) solution and aryl bromide (1.00 mmol) were added by syringe,
and the resulting solution was allowed to stir at rt for 19-20 h. The
homogeneous reaction mixture was then diluted with EtOAc (2 mL)
and filtered through a bed of silica gel, and the bed was further washed (3
ꢀ 5 mL) with EtOAc to collect all of the coupled material. The volatiles
were removed in vacuo to afford the crude product that was subsequently
purified by flash chromatography on silica gel.
N-(m-Tolyl)-3-aminopyridine (Table 5, entry 7). Following
the general procedure using 3-bromotoluene (121 μL, 1.00 mmol) and
3-aminopyridine (113 mg, 1.20 mmol), the reaction was stirred for 20 h
at rt. Column chromatography on silica gel (eluting with 40% EtOAc/
hexanes) afforded the product as an off-white solid (180 mg, 98%). 1H
NMR (400 MHz, CDCl3) δ 8.39 (br s, 1H), 8.17 (br s, 1H) 7.41 (dd, J =
8.4, 1.6 Hz, 1H), 7.21-7.17 (m, 2H), 6.91 (s, 1H), 6.90 (d, J = 8.4 Hz,
1H), 6.83 (d, J = 7.2 Hz, 1H), 5.81 (br s, 1H), 2.33 (s, 3H).40
2,6-Dimethyl-N-(m-tolyl)aniline (Table 5, entry 8). Follow-
ing the general procedure using 3-bromotoluene (121 μL, 1.00 mmol)
and 2,6-dimethylaniline (148 μL, 1.20 mmol), the reaction was stirred
for 19 h at rt. Column chromatography on silica gel (eluting with 30%
EtOAc/hexanes) afforded the product as an off-white solid (196 mg,
93%). 1H NMR (400 MHz, CDCl3) δ 7.15-7.09 (m, 3H), 7.06 (t, J =
7.6 Hz, 1H), 6.59 (d, J = 7.2 Hz, 1H), 6.36 (s, 1H), 6.32 (d, J = 8.0 Hz,
1H), 5.15 (br, 1H), 2.26 (s, 3H), 2.23 (s, 6H).11
General Procedure for Negishi Coupling (Table 6). In a
5 mL round-bottom flask under argon containing zinc dust/powder and
PdCl2(Amphos)2 was added a solution of 2 wt % of TPGS-750-M. N,N,
N0,N0-Tetramethylethylenediamine (TMEDA) was added at rt followed
by the addition of alkyl halide (2.0-3.0 mmol) and aryl or alkenyl
bromide (1 mmol). The flask was stirred vigorously at rt for 12-48 h.
The reaction mixture was then filtered through a plug of silica (10 g)
and washed with diethyl ether (70 mL) into a 100 mL flask containing 2 g
ofsilica. Solvents wereremovedundervacuum. The residuewasloadedon
silica gel and purified by flash chromatography to afford the product.
Ethyl 4-Cyclohexylbenzoate (Table 6, entry 1). Following
the general procedure, using zinc dust (195 mg, 3 mmol), PdCl2-
(Amphos)2 (3.5 mg, 0.005 mmol), 2 wt % of TPGS-750-M (3 mL),
TMEDA (116 mg, 1 mmol), bromocyclohexane (407 mg, 2.5 mmol),
and ethyl bromobenzoate (229 mg, 1 mmol), the reaction was stirred
for 48 h at rt. Column chromatography on silica gel (eluting with 1% Et2O/
petroleum ether) afforded the product (174 mg, 75%). 1H NMR (500 MHz,
CDCl3) δ 7.97 (d, J = 8.0 Hz, 2H), 7.27 (d, J = 8.0 Hz, 2H), 4.37 (q, J = 7.0
Hz, 2H), 2.56-2.55 (m, 1H), 1.87-1.84 (m, 4H), 1.43-1.38 (m, 9H).41
Ethyl 4-[(4-Ethoxycarbonyl)phenyl]butanoate (Table 6,
entry 2). Following the general procedure, using zinc dust (195 mg,
(E)-n-Butyl 3-(2-Acetamido-4-methoxyphenyl)acrylate.
N-(3-Methoxyphenyl)acetamide (41 mg, 0.25 mmol), n-butyl acrylate
(64 mg, 0.50 mmol), 1,4-benzoquinone (27 mg, 0.25 mmol), AgNO3
(85 mg, 0.5 mmol), and [Pd(MeCN)4](BF4)2 (11 mg, 0.025 mmol)
4388
dx.doi.org/10.1021/jo101974u |J. Org. Chem. 2011, 76, 4379–4391